JNJ - Johnson & Johnson closes acquisition of biotechnology company Proteologix
2024-06-21 07:47:27 ET
More on Johnson & Johnson
- Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Johnson & Johnson: Market Will Regret The Overreaction
- Johnson & Johnson (JNJ) Bernstein's 40th Annual Strategic Decisions Conference - (Transcript)
- J&J applies for FDA approval of Tremfya for Crohn's disease
- J&J Phase 3 study shows subcutaneous Tremfya effective in Crohn's